Clinical trial
A Prospective Observational Study to Evaluate the Efficacy of Lodoz in a Population of Hypertensive Patients
NCT01080742 is registered in ClinicalTrials.gov with Merck KGaA, Darmstadt, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study to Evaluate the Efficacy of Lodoz in a Population of Hypertensive Patients
- Lead sponsor
- Merck KGaA, Darmstadt, Germany
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- December 31, 2011
- Enrollment
- 1,007 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.